Medtronic (MDT) Tariff Impact Reduces Estimates to $250 Million

Medtronic plc (MDT) CEO Geoffrey Martha announced on June 8 that the company expects a tariff impact of $250 million for fiscal 2027, down from a previous estimate of $300 million. This figure includes $75 million expected in the first quarter. The reduction is due to supply chain adjustments, although Martha indicated that future tariff threats could alter these forecasts. Medtronic allocates $5 billion to $6 billion annually for innovation and reported a 78% revenue increase in cardiac ablation amidst ongoing cost pressures.